Trim 30% on MACD signal; retain 70% under dual-stop and put-spread hedge through Q3 2026 catalyst
Underweight maintained with 30% trim execution via MACD histogram zero-crossing. The tier-1 validated operational inflection (Q2 2026: revenue +25.4% YoY, GM +1,290 bps to 40.4%, normalized EBITDA tripling, FCF +$4.45B) supports retaining 70% position, but window-maximum technical extension (RSI cooling, MACD peaked Sept 25 at price high, 10 EMA and VWMA breaks) and Q3 2026 earnings binary within 4-6 weeks require disciplined asymmetric defense. The $107 tactical stop captures catalyst-timeline downside (~7% from $112.50 reference) while the $99.85 structural stop provides thesis-level invalidation — whichever fires first. The $100-110 put spreads hedge the binary without naked-short exposure on a beta-2.23 name with documented 15-25% single-session gap risk. Full Sell is rejected per 09-25 symmetric discipline: tier-1 floor ($81.96 200 SMA rising) must be respected, and the 30% trim + dual-stop + put-spread architecture delivers asymmetric defense without violating operational inflection thesis. Price target $108 reflects post-trim consolidation floor, not bearish anchoring.
| Position | Action |
|---|---|
| MACD histogram crosses zero | Trim 30% via market-on-close orders (NOT conditional limit orders) |
| Retain position | Hold 70% at no more than 50% of normal high-conviction weight |
| Hedge residual 70% | Buy Dec/Jan $100-110 put spreads at 1-1.5% of portfolio cost |
Intel is at an operational inflection with accelerating revenue growth, margin expansion, and multiple uncaptured catalysts, making the current pullback a high-conviction buying opportunity ahead of the Q3 earnings catalyst window.
| Indicator | Value | Signal |
|---|---|---|
| Close | $112.50 | neutral |
| 10 EMA | $116.49 | bearish |
| 50 SMA | $101.77 | bullish |
| 200 SMA | $81.96 | bullish |
| RSI(14) | 51.99 | neutral |
| MACD line | 4.87 | bearish |
| MACD signal | 5.49 | bearish |
| MACD histogram | −0.62 | bearish |
| Bollinger Mid | $113.06 | neutral |
| Bollinger Upper | $132.27 | neutral |
| Bollinger Lower | $93.85 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Price reaches $99-108 zone with constructive daily-close volume, RSI hook back above 50, and MACD bullish cross
Then: Tactical sizing reverse toward Holistic Overweight on confirmed bounce
↩ rebuts: “The bear's TTM EPS of -$2.12 signals fundamental weakness”
EV: +36% · concedes: Macro headwinds (10-year yield at 2002 highs, Fed cut probabilities at 1% for October) are valid concerns, though the semiconductor sector is decoupling from rates; GAAP net income is materially negative due to non-cash charges, which could persist until mark-to-market adjustments reverse; The stock may be priced for one leg of recovery rather than full foundry/AI catalyst upside; Near-term technicals (MACD bearish cross, below 10 EMA) are indeed bearish in the short term
Intel's operational improvements are already priced in at 54x forward earnings, while deteriorating balance sheet metrics, technical momentum exhaustion, hostile macro conditions, and lack of pre-earnings positioning all create asymmetric downside risk that outweighs the bull case.
· concedes: Q2 2026 did show +25% revenue growth and gross margin expansion to 40.4%; The stock has rallied 46% on the tape; Intel may be turning after years of structural erosion; PEG ratio would be reasonable if forward EPS estimates prove accurate; A blowout Q3 print could catalyze a re-rating
→ vs conservative: The 200 SMA at $81.96 is not a floor when the path to it is paved with deteriorating fundamentals and hostile macro; 'healthy pullback' classification fails because price closed below 10 EMA AND VWMA on same day with MACD bearish crossover confirmed
→ vs conservative: 'Hold through pullbacks' survivorship bias fallacy—the MACD bearish cross, break of 10 EMA and VWMA, close near low of day, and negative momentum histogram at -0.62 confirm we are NOT in an uptrend
→ vs conservative: Waiting for 50 SMA at $101.77 to add (9.5% drop) ignores that if 50 SMA fails at Q3 print with beta 2.23, stock blows through it and tests $82 before anyone reacts
→ vs neutral: 'Recession odds only 6%' is irrelevant probability; the relevant risk is multiple compression on long-duration, high-beta, capital-intensive cyclical with negative TTM EPS when discount rate is structurally rising—arithmetic, not bearish bias
→ vs neutral: 'Idiosyncratic optionality' with Intel18A, foundry JVs, and data center roadmap does not exist in reality—zero INTC-specific news for three weeks, paying full price for catalysts that haven't materialized
→ vs neutral: 'Chip tape is bid' argument meaningless for INTC when leaders are GPU and AI-accelerator names Intel structurally cannot replicate
| neutral |
| ATR(14) | $6.00 | neutral |
| VWMA | $117.71 | bearish |
Support: 101.77 · 93.85 · 81.96 | Resistance: 116.49 · 127.39 · 132.27 · 140.94
INTC exhibits a textbook trend-with-pullback setup: long-term (200 SMA) and medium-term (50 SMA) trends remain strongly bullish with price 37.3% and 10.5% above these levels respectively, while short-term momentum has broken down with price trading below the 10 EMA and VWMA following a MACD bearish crossover. RSI at 51.99 indicates neutral conditions with no extreme readings despite the pullback. The ATR of $6.00 reflects elevated volatility requiring wider stops (2× ATR ≈ $12), and position sizing should be reduced 30-40% versus low-volatility names. The report recommends HOLD for existing positions, advises traders to wait for support tests at the 50 SMA ($101.77) with momentum confirmation, and notes the short-term bias is bearish but the broader trend is not.
Market Cap
$594.7 Billion
Share Price
$117.96
52-Week High
$142.35
52-Week Low
$32.89
50-Day Moving Average
$101.35
200-Day Moving Average
$81.57
Forward P/E
54.02
PEG Ratio
1.36
Price to Book
6.48
Beta
2.23
Dividend Yield
0.0%
Book Value per Share
$17.36
EPS (TTM)
-$2.12
Forward EPS
$2.08
Q2 2025 Revenue
$12,859M
Q2 2025 Gross Profit
$3,542M
Q2 2025 Operating Income
-$1,286M
Q2 2025 Net Income
-$2,918M
Q2 2025 Diluted EPS
-$0.67
Q3 2025 Revenue
$13,653M
Q3 2025 Gross Profit
$5,218M
Q3 2025 Operating Income
$683M
Q3 2025 Net Income
$4,063M
Q3 2025 Diluted EPS
$0.90
Q4 2025 Revenue
$13,674M
Q4 2025 Gross Profit
$4,943M
Q4 2025 Operating Income
$580M
Q4 2025 Net Income
-$591M
Q4 2025 Diluted EPS
-$0.12
Q1 2026 Revenue
$13,577M
Q1 2026 Gross Profit
$5,347M
Q1 2026 Operating Income
$934M
Q1 2026 Net Income
-$3,728M
Q1 2026 Diluted EPS
-$0.73
Q2 2026 Revenue
$16,128M
Q2 2026 Gross Profit
$6,509M
Q2 2026 Operating Income
$1,966M
Q2 2026 Net Income
-$11,033M
Q2 2026 Diluted EPS
-$2.16
Gross Margin (TTM)
38.9%
Operating Margin (TTM)
12.2%
Net Profit Margin (TTM)
-19.8%
EBITDA Margin (TTM)
29.5%
Return on Equity (TTM)
-10.7%
Return on Assets (TTM)
1.4%
Debt-to-Equity
48.99
Current Ratio
1.60
Total Assets (Q2 2026)
$202.4B
Total Liabilities (Q2 2026)
$99.3B
Stockholders' Equity (Q2 2026)
$87.5B
Cash and ST Investments (Q2 2026)
$29.7B
Total Debt
$50.5B
Net Debt
$37.7B
Goodwill and Intangibles
$23.0B
Net PPE
$105.7B
Inventory (Q2 2026)
$12.5B
Revenue YoY Growth (Q2 2026)
+25.4%
Normalized EBITDA YoY Growth
+210%
Normalized EBITDA (Q2 2026)
$5.46B
TTM Free Cash Flow
$4.87B
Quarterly CapEx Range
$2.4B - $3.6B
Shares Outstanding (Q2 2025)
4.38B
Shares Outstanding (Q2 2026)
5.04B
Strengths
Concerns
Intel is undergoing a strategic turnaround under new CEO Lip-Bu Tan with strong operational improvements: Q2 2026 revenue surged 25.4% YoY to $16.1B, gross margins expanded 1,290 basis points to 40.4%, and normalized EBITDA more than tripled to $5.46B, confirming underlying business health. However, headline profitability remains severely distorted by non-cash mark-to-market losses ($12.7B in "Other Income/Expense") and $12.5B in securities-related gains, resulting in negative TTM net margin of -19.8% and TTM EPS of -$2.12; the stock also carries stretched valuation (54x forward P/E), high leverage (D/E 48.99), elevated beta (2.23), and significant dilution risk from equity raises funding the foundry build-out. The investment case hinges on successful execution of the foundry strategy, sustained AI/Data Center demand, and gross margin expansion toward the 45%+ target.
Macro: Decidedly mixed for risk assets but clearly hostile to long-duration equities. The 10-year Treasury yield touched its highest level since 2002 and posted its biggest monthly gain since 2022 in September; mortgage rates hit 7.58% near a 3-year high; 30-year Treasury climbed to its highest since 2002. A chorus of Fed officials warned inflation remains too high; Goldman Sachs warned rising rates threaten the U.S. debt trajectory; Moody's Zandi warned higher rates are already damaging the economy. The Iran war is driving inflation higher beyond just oil. Despite this, equities have been surprisingly resilient—S&P 500 and Nasdaq printed new record highs led by Nvidia and AMD. Tech leadership and AI-driven chip demand have decoupled semiconductors from the rates narrative for now. Fed rate-cut odds are essentially 1% for October 2026; only beyond July 2027 does probability cross 50%. US recession odds are low at 6% and falling. The market is pricing a soft-landing/late-cycle regime that historically rewards AI/GPU winners and punishes CPU/legacy semis.